Coverage
-
January 10, 2025
The Second Circuit reopened an advocacy group's lawsuit Friday claiming a Pfizer Inc. fellowship program unlawfully excluded white and Asian applicants, upending a March panel decision that said the group failed to pinpoint who was harmed.
2 other articles on this case.
View all »